Molecular genetic alterations on chromosomes 11 and 22 in ependymomas
暂无分享,去创建一个
M. Westphal | U. Heinemann | L. Kluwe | K. Lamszus | U. Finckh | L. Lachenmayer | R. Fillbrandt | D. Stavrou | W. Höppner | Uta Heinemann | Regina Fillbrandt
[1] M. Westphal,et al. Allelic Losses in Neurofibromatosis 2‐Associated Meningiomas , 2000, Journal of neuropathology and experimental neurology.
[2] S. Antonarakis,et al. Mutation nomenclature extensions and suggestions to describe complex mutations: A discussion , 2000 .
[3] A. Ouweland,et al. ©1999 Cancer Research Campaign Article no. bjoc.1999.0822 , 2022 .
[4] G. Reifenberger,et al. Molecular genetic analysis of ependymal tumors. NF2 mutations and chromosome 22q loss occur preferentially in intramedullary spinal ependymomas. , 1999, The American journal of pathology.
[5] M. Westphal,et al. Allelic losses at 1p, 9q, 10q, 14q, and 22q in the progression of aggressive meningiomas and undifferentiated meningeal sarcomas. , 1999, Cancer genetics and cytogenetics.
[6] V. Álvarez,et al. Multiple endocrine neoplasia type 1 (MEN1): clinical heterogeneity in a large family with a nonsense mutation in the MEN1 gene (Trp471Stop) , 1999, Clinical endocrinology.
[7] D. Housman,et al. Identification and mutation analysis of DOC-1R, a DOC-1 growth suppressor-related gene. , 1999, Biochemical and biophysical research communications.
[8] F. Collins,et al. Menin Interacts with the AP1 Transcription Factor JunD and Represses JunD-Activated Transcription , 1999, Cell.
[9] P. Chanson,et al. Germ-line mutation analysis in patients with multiple endocrine neoplasia type 1 and related disorders. , 1998, American journal of human genetics.
[10] G. Evans,et al. Loss of heterozygosity in squamous cell carcinomas of the head and neck defines a tumor suppressor gene region on 11q13. , 1998, Cancer genetics and cytogenetics.
[11] R. Mccomb,et al. Pathology and Genetics of Tumours of the Nervous System , 1998 .
[12] M. Sawicki,et al. Deletion mapping of endocrine tumors localizes a second tumor suppressor gene on chromosome band 11q13 , 1998, Genes, chromosomes & cancer.
[13] B. Teh,et al. A large multiple endocrine neoplasia type 1 family with clinical expression suggestive of anticipation. , 1997, The Journal of clinical endocrinology and metabolism.
[14] T. Mohandas,et al. Molecular studies of an ependymoma-associated constitutional t(1;22)(p22;q11.2). , 1997, Cytogenetics and cell genetics.
[15] F. Collins,et al. Germline mutations of the MEN1 gene in familial multiple endocrine neoplasia type 1 and related states. , 1997, Human molecular genetics.
[16] Y Wang,et al. Positional cloning of the gene for multiple endocrine neoplasia-type 1. , 1997, Science.
[17] I. Pollack,et al. The Molecular Biology of Ependymomas , 1997, Brain pathology.
[18] P. Cogen,et al. Molecular genetic analysis of chromosome arm 17p and chromosome arm 22q DNA sequences in sporadic pediatric ependymomas , 1996, Genes, chromosomes & cancer.
[19] J. Bruce,et al. Frequent type 2 neurofibromatosis gene transcript mutations in sporadic intramedullary spinal cord ependymomas. , 1996, Neurosurgery.
[20] M. Endo,et al. Multiple endocrine neoplasia type 1 associated with spinal ependymoma. , 1996, Internal medicine.
[21] J. Biegel,et al. Exon scanning for mutations of the nf2 gene in pediatric ependymomas, rhabdoid tumors and meningiomas , 1995, International journal of cancer.
[22] G. Thomas,et al. Molecular analysis of genetic changes in ependymomas , 1995, Genes, chromosomes & cancer.
[23] C. Wernicke,et al. Involvement of chromosome 22 in ependymomas. , 1995, Cancer genetics and cytogenetics.
[24] C. C. Tijssen,et al. Familial anaplastic ependymoma: evidence of loss of chromosome 22 in tumour cells. , 1994, Journal of neurology, neurosurgery, and psychiatry.
[25] J. Sawyer,et al. Chromosome aberrations in four ependymomas. , 1994, Cancer genetics and cytogenetics.
[26] D. Cochrane,et al. Cytogenetic analysis of 109 pediatric central nervous system tumors. , 1993, Cancer genetics and cytogenetics.
[27] J. Weber,et al. A microsatellite-based index map of human chromosome 11. , 1993, Human molecular genetics.
[28] B. Scheithauer,et al. Cytogenetic and loss of heterozygosity studies in ependymomas, pilocytic astrocytomas, and oligodendrogliomas , 1992, Genes, chromosomes & cancer.
[29] J. Fletcher,et al. Cytogenetic evidence for a chromosome 22 tumor suppressor gene in ependymoma. , 1992, Cancer genetics and cytogenetics.
[30] A. Raap,et al. Interphase cytogenetics: a new tool for the study of genetic changes in brain tumors. , 1992, Journal of neurosurgery.
[31] G. Basso,et al. Cytogenetic t(11;17)(q13;q21) in a pediatric ependymoma. Is 11q13 a recurring breakpoint in ependymomas? , 1992, Cancer genetics and cytogenetics.
[32] J. Shepherd. The natural history of multiple endocrine neoplasia type 1. Highly uncommon or highly unrecognized? , 1991, Archives of surgery.
[33] P. Kelly,et al. Posterior fossa ependymomas: report of 30 cases and review of the literature. , 1991, Neurosurgery.
[34] D. Bigner,et al. Cytogenetics of human brain tumors. , 1990, Cancer genetics and cytogenetics.
[35] M. Stratton,et al. Cytogenetic abnormalities in human ependymomas , 1989, International journal of cancer.
[36] P. Kelly,et al. A cytogenetic study of 53 human gliomas. , 1989, Cancer genetics and cytogenetics.
[37] P. Cin,et al. Cytogenetic findings in a supratentorial ependymoma. , 1988, Cancer genetics and cytogenetics.
[38] S. Mørk,et al. Ependymoma. A follow‐up study of 101 cases , 1977, Cancer.
[39] Vincent Fm. Posterior-fossa ependymomas. , 1977 .
[40] D. Louis,et al. Analysis of the neurofibromatosis 2 gene in human ependymomas and astrocytomas. , 1994, Cancer research.